|Bid||287.79 x 800|
|Ask||287.81 x 900|
|Day's Range||282.82 - 289.57|
|52 Week Range||225.65 - 355.88|
|Beta (3Y Monthly)||1.08|
|PE Ratio (TTM)||15.74|
|Forward Dividend & Yield||2.20 (0.80%)|
|1y Target Est||N/A|
Rising health costs have become a burden for many Americans, but many people still may be unaware of one benefit they get, the health savings account. Personal finance expert Jean Chatzky joins Yahoo Finance to discuss the benefits of HSAs.
Shares of UnitedHealth Group are slipping after a downgrade from BMO Capital on uncertainty associated with the 2020 election. UnitedHealth and Humana are closely tied to Medicare Advantage, which BMO speculates will suffer from lower profit margins and slower enrollment growth if the U.S. gets a new president in 2020.
Mizuho recommended buying three health insurer stocks as it initiated coverage of the sector Thursday. The Analyst Mizuho's Ann Hynes initiated coverage of Humana Inc . (NYSE: HUM ) with a Buy rating ...
Louisville-based Humana Inc. has seen another change on its board of directors. The company disclosed through a filing with the Securities and Exchange Commission that Karen DeSalvo would leave the board, effective October 15, in order to avoid the appearance of any conflict of interest in connection with her plan to pursue a new executive opportunity. It's not clear what opportunity DeSalvo is pursuing.
UnitedHealth's (UNH) higher revenues, strength in both segments -- UnitedHealthcare and Optum -- plus membership growth leads to earnings outperformance.
Humana's (HUM) Medicare plans to help the State of Florida Medicare-eligible retirees and their eligible dependents achieve better health outcomes.
The Insider Monkey team has completed processing the quarterly 13F filings for the June quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled them to adjust their equity holdings so as […]
He was formerly deputy general counsel and the corporate secretary for Humana Inc. Now, he's moved to the 'first chair' at a Louisville-based health care organization that is one of the area's largest employers.
Humana and the University of Pittsburgh School of Medicine estimate that a major portion of health care spending is wasted.
Humana Inc. has expanded and changed the responsibility of two members of its C-suite. The company announced Monday that Timothy Huval will become chief administrative officer. Sam Deshpande has formally been named chief technology and risk officer, according to a news release.
Humana (HUM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
(Bloomberg Opinion) -- After months of promising a big beautiful health-care plan, President Donald Trump finally delivered something.Escaping briefly from the impeachment drama going on in Washington, Trump used a Thursday speech in Florida to announce a new executive order aimed at steering more seniors into privately managed Medicare Advantage plans instead of traditional Medicare. The president is selling it as part of a broader effort to lower costs and protect seniors from Democratic proposals such as "Medicare for All" that he said would “raid Medicare to fund a thing called socialism.” It served as a preview of the rhetoric the president will use as he attempts to gain an advantage on a strong issue for Democrats. It's easy to see why he's going this way. Change is scary. Medicare for All, which would end most private insurance and put all Americans on a government-run plan, gets a mixed reception in polls. But health care is still a minefield for Trump. Crying "socialism" at efforts to change America’s health system isn’t new. Medicare was decried as a capitalism-killer in the 1960s. The Affordable Care Act got the same treatment, even though it echoed ideas that came from a conservative think tank. Now Medicare is so well-regarded that the president is making its "defense" a centerpiece of his health agenda. As for the ACA, it’s getting increasingly popular, and Republican efforts to repeal it contributed to their losing control of the House.In that context, it's worth looking at what Democratic proposals would do. Rather than destroying Medicare, they'd arguably improve it and expand it. The current program isn't perfect. It includes substantial premiums, as well as co-pays, deductibles, and co-insurance for using care. There's no cap on out-of-pocket expenses for people in traditional Medicare, which can create a significant financial burden.Medicare for All – essentially universal health coverage – would substantially extend the benefits available to seniors and eliminate all out-of-pocket costs. The plan’s coverage of long-term care would remove a huge weight from the elderly and their families. There are some potential trade-offs: Wait times could increase as more people join the program, and taxes would increase. Even so, it’s hard to frame the plan as a definite negative for most seniors. Medicare for All is also the least likely of the Democratic health plans to become law. Most of the party’s presidential candidates support less disruptive policies that would still help seniors. Some would expand benefits, most would cap out-of-pocket expenses, and some would do both. By contrast, Trump's proposal may not do all that much for seniors.The idea behind Medicare Advantage is that competition between private insurers like UnitedHealth Group Inc. and Humana Inc. that sell these plans will boost efficiency and decrease costs. People who sign up for these plans get access to expanded benefits, out-of-pocket caps, and potentially lower premiums. In return, though, they face more limited access to a narrower set of doctors – the very thing the president says Democratic plans will bring. Cost savings and profits have to come from somewhere, after all.The executive order reportedly includes some additional cost-control efforts, including a fraud crackdown and an expansion of the role of nurse practitioners. They are unlikely to have a major impact. A reported boost to tax-advantaged health-savings accounts will largely benefit the wealthy. Moreover, the order may open the president to accusations that he’s trying to privatize Medicare. Republicans also will have to contend with the Democratic counter-argument that more Americans should get Medicare Advantage-type benefits without subsidizing insurer profits. There’s also the salient fact that insurers who run these plans have over-billed U.S. taxpayers by nearly $30 billion in the last three years alone, according to the Department of Health and Human Services’ own estimates . Ranging into other health-care areas, Trump’s speech also touted his various drug-pricing initiatives, failing to mention those that have failed to make it to the finish line. Other vulnerabilities remain, too, like the administration's support for a lawsuit that could kill the ACA even as the president makes a contradictory pledge to protect people with pre-existing conditions.Perhaps inevitably, Trump couldn't stay away from the impeachment inquiry. Towards the end of his Wednesday remarks, he implied that drugmakers unhappy about his efforts might be involved. If Trump wants to turn health care into a strength, he’ll have to do better than that. To contact the author of this story: Max Nisen at firstname.lastname@example.orgTo contact the editor responsible for this story: Beth Williams at email@example.comThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Max Nisen is a Bloomberg Opinion columnist covering biotech, pharma and health care. He previously wrote about management and corporate strategy for Quartz and Business Insider.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.
President Donald Trump will be talking about health care this afternoon, pulling the industry into the battle over his political future. The president will issue an executive order on Medicare that could bump up health-care stocks a bit. Details about the executive order have been scarce, but reports from the Wall Street Journal and the Washington Post this week have suggested that it will focus on Medicare Advantage, the privately-managed Medicare plans that have proven increasingly popular with seniors.
Shares of Humana Inc. fell 1.0% in midday trading, to pace the declines in its health care-sector peers, after BMO Capital analyst Matt Borsch downgraded the health-care benefits plan company, citing a re-rating of companies given political and health policy uncertainty. Borsch cut his rating on Humana to market perform, after being at outperform for at least the past two years, and slashed his price target to $290 from $345. Borsch also downgraded UnitedHealth Group Inc. to market perform from outperform, and cut his price target to $249 from $292. Meanwhile, he upgraded Cigna Corp. to outperform from market perform. He wrote in a note to clients that the ratings changes reflect his "new ratings bias toward lower valuation as well business mix that we think represents a better 'hedge' against political and health policy uncertainty." Humana's stock has shed 3.8% over the past three months, UnitedHealth shares have tumbled 11.5% and Cigna's stock has lost 3.7%, while the SPDR Health Care Select Sector ETF has slipped 2.6% and the Dow Jones Industrial AVerage has tacked on 1.4%.
Uncertainty surrounding the 2020 U.S. election outcome spurs BMO Capital to downgrade healthcare providers UnitedHealth Group and Humana, though Cigna is upgraded for similar reasons.
Growth in government and pharmacy benefit management businesses as well as share buybacks should enhance the third-quarter earnings of health insurers.